Impact of real-time, dose-escalated permanent seed implant brachytherapy in intermediate-risk prostate cancer

PURPOSE: To retrospectively evaluate biochemical control and toxicity in patients who underwent 125I seed brachytherapy (BT) for intermediate-risk prostate cancer (PCa). MATERIALS AND METHODS: Between January 2004-December 2014, 395 patients with intermediate-risk PCa underwent 125I BT. Of these, 11...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Rep Pract Oncol Radiother
Prif Awduron: Pons-Llanas, O., Collado-Ballesteros, E., Roldan-Ortega, S., Conde-Moreno, A., Celada-Alvarez, F., Martínez-Arcelus, F., Pérez-Calatayud, M.J., Carmona-Meseguer, V., Gimeno-Olmos, J., Forner-Ferrer, V., Tormo-Micó, A., Perez-Calatayud, J., López-Torrecilla, J.
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: Via Medica sp. z o.o. sp. k 2020
Pynciau:
Original Research Article
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC7256233/
https://ncbi.nlm.nih.gov/pubmed/32494221
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.rpor.2020.04.014
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg